Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mark Corrigan


  • Director at Wave Life Sciences Ltd. (WVE), 2019-09-06
  • Director at Nabriva Therapeutics Plc (NBRV), 2019-08-01
  • Director at Novelion Therapeutics Inc. (NVLN), 2018-08-13
  • Director at Nabriva Therapeutics Plc (NBRV), 2017-06-28
  • Director at Colucid Pharmaceuticals Inc. (CLCD), 2017-03-01
  • Director at Epirus Biopharmaceuticals Inc. (EPRS), 2015-06-08
  • Director at Cubist Pharmaceuticals Inc (CBST), 2015-01-21
  • Director at Avanir Pharmaceuticals Inc. (AVNR), 2014-04-03
  • Officer at Sepracor Inc (SEPR), 2009-10-22
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CBST $80.00 5,000 Director 5,498 2014-02-27 Filing
CBST $54.60 14,000 Director 3,156 2013-05-24 Filing
ZLCS $0.77 112,850 Officer, Director 844,090 2013-01-15 Filing
CBST $41.01 10,000 Director 3,156 2012-07-24 Filing
ZLCS $1.14 68,105 Officer, Director 706,940 2012-01-17 Filing